Trial Profile
Longitudinal imaging of tau accumulation in the preclinical stages of AD
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2024
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Acronyms LUNAR
- 05 Dec 2020 Planned End Date changed from 18 Aug 2019 to 18 Aug 2021.
- 08 Mar 2016 New trial record